semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Migraine Photophobia Phonophobia Male and Female subjects 65 years of age Primary diagnosis of migraine attack with aura or migraine attack without aura Migraine history of averaging at least 1 migraine attack per month but averaging not more than 6 migraine attacks per month over the prior year Female subjects must use an effective form of birth control Listing of additional are available through the Sponsor  Excluding subjects with a history of other serious events causing secondary headaches Excluding subjects with a current medical condition that could interfere with the overall study intent or affect the absorption, distribution, metabolism, or excretion of the study medication Excluding subjects with a history or current medical condition that could confound the study results or use of a concomitant medication that could interfere with the study drug Listing of additional are available through the Sponsor
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 14.0-65.0,  Migraine Male and female patients aged 14-65, inclusive Diagnosis of NDPH or TM according to the Silberstein-Lipton criteria Ability to read and understand an informed consent form and study procedures  Pregnancy Subjects with any disease or condition that would result in unreliable data or confound the data obtained for this study, as determined by the principal investigator
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 15.0-19.0,  Teen Pregnancy The following will determine for the study: 1. African American and Latino primiparous pregnant or newly parenting (0-6 weeks); 2. Age 15-18 years inclusive; and 3. Teens who are 19 years old if they have not graduated from high school  Non-English speaking; 2. Any serious medical condition or disability that would interfere with the participant responding adequately to evaluation measures; 3. Obvious cognitive impairment that interferes in participating in informed consent; 4. Incarceration at enrollment or during the study
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 8.0-18.0,  Migrainous Headache Males or Females age 8-18 years 2. Girls 11 years or older must have a negative urine/serum pregnancy test. 3. Diagnosis of pediatric migrainous headache. The for pediatric migraine headache based on the most recent ICHD are listed below. The requirement of 5 attacks (A) will not be required for this study, this making the diagnosis migrainous headache. As described elsewhere in the protocol, this change is required to make the study applicable to ED patients who require treatment before five attacks have occurred  Evidence that headache is due to a secondary underlying disorder based on history or physical examination. 2. Pregnant or lactating females. 3. Any investigational drug use within 30 days. 4. Known to have a contraindication to metoclopramide or valproic acid such as pregnancy, liver disease, hematologic disease, or metabolic disease. 5. Have used metoclopramide (or other antidopaminergic medications) or valproic acid within two days of presentation. 6. Severe developmental disorders or mental retardation if insufficient information can be obtained to make a clear diagnosis of migraine or judge headache severity. 7. If patients re-present to the ED, they can not be re-enrolled
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Migraine Disorders Diagnosis of migraine (with or without aura) or cluster headache according to the International Classification of Headache Disorders, Version 2 (ICHD-II) History of migraine or cluster headache persisting for at least 6 months Migraine: One to 6 attacks of moderate or severer headaches per month during the 2 months prior to enrollment Cluster Headache: Each attack persisting for at least 45 minutes Written informed consent obtained from the patient. When a patient is a minor, written informed consent from his/her proxy consenter (e.g., person with parental authority) will also be required  History of hypersensitivity to any of the ingredients of 5-HT1B/1D receptor antagonists (e.g., triptans) or serious AE due to treatment with these drugs History of serious adverse event attributable to treatment with Imigran® Injection 3 History of myocardial infarction, current or previous history of ischemic heart disease or its symptoms/signs, or current history of atypical variant angina (coronary arteriospasm) Previous history of cerebrovascular disorder or transient cerebral ischemic attack Current or previous history of peripheral angiopathy (including Raynaud's syndrome) Systolic blood pressure (SBP) >160 mmHg or diastolic blood pressure (DBP) >95 mmHg at the start of treatment period Current familial hemiplegic migraine, basilar migraine, or sporadic hemiplegic migraine Current abuse of ergotamine or dihydroergotamine-containing preparations or triptans Pregnant women, lactating mothers, women who may be pregnant, or women of childbearing potential using no appropriate contraceptive measures
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Familial Hemiplegic Migraine Patients: Diagnosis of familial hemiplegic migraine (IHS-classification criteria) caused by mutations in the CACNA1A gene and the ATP1A2 gene. Controls: Healthy volunteers  Controls: No primary headache in their own history 2) Patients and controls A history of cerebrovascular disease and other CNS disease A history of serious somatic and mental disease A history suggesting ischaemic heart disease A history of hypo or hypertension Daily intake of medication apart from oral contraceptives Abuse of alcohol or medicine (opioid analgesics) Pregnant or breastfeeding women. On the study day
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Post-Dural Puncture Headache American Society of Anesthesiologists status 1 to 2 Must have provided written informed consent = or < 6cm cervical dilation Fetus 37 to 42 weeks gestation Must be able to read and write English well enough to provide written informed consent  BMI = or > 40 Multiple gestation pregnancy Known contraindications to use of epidural analgesia Pregnancy-induced hypertension Investigator concern for maternal or neonatal welfare Receipt of spinal or epidural anesthesia within 14 days of labour epidural request Women with chronic headaches (defined as headaches that occur 15 or more days per month for more than 3 months) Already participated in study History of narcotic abuse
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 10.0-17.0,  Headache diagnosis of chronic daily headache based on definition of 15 or more headache days per month measured by a prospective daily headache diary females or males between the ages of 10-17 PedMIDAS Disability Score > 20, indicating at least moderate disruption in daily activities  medication overuse as defined in the ICHD-II (NSAID or other simple analgesic on ≥ 15 days/ month for >3 months; triptan intake in any formulation ≥ 10 days/month on a regular basis of ≥ 3 months) current treatment with amitriptyline no other current prophylactic antimigraine medication within a period equivalent to < 5 half-lives of that medication before entering the screening phase other chronic pain condition such as juvenile primary fibromyalgia syndrome, complex regional pain syndrome-II abnormal findings on EKG current or past history of severe orthostatic intolerance or severe levels of orthostatic dysregulation (orthostatic hypotension or postural orthostatic tachycardia syndrome) significant documented developmental delay or impairments such as autism, cerebral palsy or mental retardation present or lifetime psychiatric diagnosis that meets DSM-IV for bipolar disorder, major depressive disorder or psychosis PedMIDAS Disability Score of > 140, indicating need for multi-systemic therapies to address very significant level of disability youth who are pregnant, or those females who are sexually active and not using a medically accepted form of contraception (barrier or hormonal methods) or do not agree to be abstinent during the study
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 17.0-19.0,  Obesity All female college freshmen at the University of Oregon will be invited to participate in the study  Any participant that meets for an eating disorder at any assessment point will be excluded from the study Any participant with BMI below 5% for their age group will be excluded to avoid health risks Any participant who does not report some form of body dissatisfaction will be excluded from the study
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Migraine Has at least 1 year history of migraine (with or without aura) Females of child bearing potential must use acceptable contraception throughout trial  Is pregnant/breast-feeding (or is a female expecting to conceive during study period) Has history or evidence of stroke/transient ischemic attacks, heart disease, coronary artery vasospasm, other significant underlying cardiovascular diseases, uncontrolled hypertension (high blood pressure), uncontrolled diabetes, or human immunodeficiency virus (HIV) disease Has major depression, other pain syndromes that might interfere with study assessments, psychiatric conditions, dementia, or significant neurological disorders (other than migraine) Has a history of gastric, or small intestinal surgery, or has a disease that causes malabsorption Has a history of cancer within the last 5 years
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Hereditary Angioedema (HAE) years of age or older Documented diagnosis of HAE (Type I or II) Willing and able to give informed consent Acute HAE attack at time of presentation  Receipt of an investigational drug or device, within 30 days prior to study treatment, other than DX-88 (ecallantide) Pregnancy or breastfeeding Receipt of non-investigational C1-INH or DX-88 within 72 hours of treatment Patients eligible for current, ongoing clinical trial in which DX 88 (ecallantide) is offered
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Hereditary Angioedema (HAE) years of age or older Executed informed consent Documented diagnosis of HAE (Type I or II) Presentation at the site within 8 hours of patient recognition of an moderate to severe HAE acute attack  Receipt of an investigational drug or device, within 30 days prior to study treatment Receipt of non-investigational C1-INH within 7 days of treatment Receipt of DX-88 (ecallantide) within 3 days prior to study treatment Diagnosis of acquired angioedema (AAE), estrogen-dependent angioedema or drug-induced angioedema (including angiotensin-converting enzyme inhibitor induced angioedema) Pregnancy or breastfeeding
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 5.0-20.0,  Migraine Thrombosis Thrombophilia Patients diagnosed as suffering from migraine according to the Neurologic criteria
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 45.0-65.0,  Hormone Replacement Therapy Written informed consent Postmenopausal status (amenorrhea for at least 12 months) years of age Application of estrogen or cyclic estrogen/progestin preparation other than the study medication for at least 6 months prior to Visit 1 Relevant impairment of well-being and mood inspite of estrogen therapy (confirmed by questionnaire scores) BMI<33kg/m2  Uterine bleeding of unknown etiology within the last 2 years Previous or existing or suspected carcinoma of the breast Any malignant disease in the last 5 years Endometrial double layer thickness > 5 mm History of thromboembolic events or existing thromboembolic processes Prior hormone replacement therapy with androgens within 12 months prior to Visit 1 Major life events within the last 12 months prior to Visit 1